The US Supreme Court ruling upholding the Affordable Care Act re-injects a sense of urgency into the transformation of an industry that represents nearly one-fifth of the US economy. Implementation deadlines that once seemed far off are now rapidly approach, putting fresh pressure on health organizations to devise innovative ways of delivering high-quality, affordable care.
The Court ruled that a core provision of the Affordable Care Act (the requirement that every American carry health insurance) is a tax and as such, is constitutional. The ruling also permits the federal government to pursue a broad expansion of the Medicaid health program for the poor, removed the penalty for states that choose not to expand Medicaid to 133% of the Federal Poverty Level.
This report from the Health Research Institute shares analysis of the implications of the ruling for health insurers, providers, pharmaceutical and life sciences, state governments, and employers.